Atrys Health Past Earnings Performance

Past criteria checks 0/6

Atrys Health's earnings have been declining at an average annual rate of -62.6%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 55.9% per year.

Key information

-62.6%

Earnings growth rate

-50.6%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate55.9%
Return on equity-10.6%
Net Margin-14.8%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Is Atrys Health, S.A. (BME:ATRY) Trading At A 44% Discount?

Sep 09
Is Atrys Health, S.A. (BME:ATRY) Trading At A 44% Discount?

The Returns At Atrys Health (BME:ATRY) Aren't Growing

Jun 27
The Returns At Atrys Health (BME:ATRY) Aren't Growing

Returns On Capital Are Showing Encouraging Signs At Atrys Health (BME:ATRY)

Nov 26
Returns On Capital Are Showing Encouraging Signs At Atrys Health (BME:ATRY)

Atrys Health (BME:ATRY) Might Have The Makings Of A Multi-Bagger

Aug 12
Atrys Health (BME:ATRY) Might Have The Makings Of A Multi-Bagger

Did You Miss Atrys Health's (BME:ATRY) Whopping 387% Share Price Gain?

Feb 02
Did You Miss Atrys Health's (BME:ATRY) Whopping 387% Share Price Gain?

Atrys Health, S.A. (BME:ATRY) Shares Could Be 33% Above Their Intrinsic Value Estimate

Dec 11
Atrys Health, S.A. (BME:ATRY) Shares Could Be 33% Above Their Intrinsic Value Estimate

Revenue & Expenses Breakdown
Beta

How Atrys Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BME:ATRY Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23206-3020
30 Jun 23222-3410
31 Mar 23207-2810
31 Dec 22163-2630
30 Sep 22181-2310
30 Jun 22171-2210
31 Mar 22148-2310
31 Dec 21124-2310
30 Sep 2196-1610
30 Jun 2167-810
31 Mar 2151-700
31 Dec 2034-600
30 Sep 2026-200
30 Jun 2019-100
31 Mar 2018-100
31 Dec 1917000
30 Sep 1914000
30 Jun 1912000
31 Mar 1911000
31 Dec 189000
30 Sep 189000
30 Jun 189000
31 Mar 188000
31 Dec 178000
30 Sep 177010
30 Jun 177010
31 Mar 176010
31 Dec 166020
31 Dec 153100
31 Dec 142000
31 Dec 133000

Quality Earnings: ATRY is currently unprofitable.

Growing Profit Margin: ATRY is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ATRY is unprofitable, and losses have increased over the past 5 years at a rate of 62.6% per year.

Accelerating Growth: Unable to compare ATRY's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ATRY is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2%).


Return on Equity

High ROE: ATRY has a negative Return on Equity (-10.61%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.